What is Kura Oncology's income tax?

Kura Oncology (KURA) reported income tax of $8K in Q1 2026.

How has Kura Oncology's income tax changed year-over-year?

Kura Oncology's income tax decreased by 96.5% year-over-year, from $226K to $8K.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Kura Oncology KURA Income Tax

Income Tax at other companies

Johnson & JohnsonJNJ

$755M-71.3%

AmgenAMGN

$265M+9.1%

ExelixisEXEL

$57.22M+24.2%

Syndax PharmaceuticalsSNDX

$0—

AbbVieABBV

$342M-8.1%

Nuvation BioNUVB

$0—

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's income tax?: Kura Oncology (KURA) reported income tax of $8K in Q1 2026.
How has Kura Oncology's income tax changed year-over-year?: Kura Oncology's income tax decreased by 96.5% year-over-year, from $226K to $8K.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.